A patented functional strain derived from healthy human breast milk

Lacticaseibacillus paracasei ET-66 is a probiotic strain isolated from healthy human breast milk. Backed by a solid patent portfolio and multiple peer-reviewed publications, ET-66 has demonstrated strong potential in oral health and upper digestive comfort, and has been successfully incorporated into several PRONULIFE® clinically validated formulations.
  

Core Areas of Application

• Oral Health: Patents demonstrate its ability to inhibit oral pathogens and support oral immune function, making it suitable for applications in food and oral care products.

• Upper Digestive Support: Research and patents highlight its role in helping maintain or improve gastrointestinal conditions, providing potential support for daily digestive comfort.
   

Functional Applications in PRONULIFE^® Formulations

ET-66 has been applied in multiple oral and digestive health formulations:

Oral Health PRONULIFE® OraProtect / OraProtect-L

  

Key Patents

Taiwan

• I639389: Food and pharmaceutical compositions of lactic acid bacteria for inhibiting oral pathogens

• I812128: Use of lactic acid bacteria or its fermentation products for maintaining or improving gastrointestinal conditions

China

• CN108338361B: Food, oral hygiene, and pharmaceutical compositions containing lactic acid bacteria for oral health

United States

• US11759487B2: Composition including probiotics for increasing oral immunoglobulin A and inhibiting oral pathogens

 
📧 Contact us: glac@glac.com.tw
 Further Reading:

1. Glac Single Strain Probiotic Powder - Live Probiotic Powder
2. PRONULIFE® Functional Probiotic Ingredients

   

References

• Lozenges with probiotic strains enhance oral immune response and health

• Viable and heat-killed probiotic strains improve oral immunity by elevating the IgA concentration in the oral mucosa

• Antibacterial activity of viable and heat-killed probiotic strains against oral pathogens